American Association for the Advancement of Science, Science Translational Medicine, 530(12), 2020
DOI: 10.1126/scitranslmed.aax6337
Full text: Unavailable
Innate defense regulator RP-182 targets CD206 high M2-like macrophages in malignant and noncancerous diseases.